Ticker
SRZNCompany Name
SURROZEN INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -31.83M | $ -3.73 | 1 | 8.54M |
3/31/2025 | $ -78.74M | $ -21.7 | 1 | 3.63M |
12/31/2024 | $ -60.6M | $ -20.66 | 1 | 2.93M |
9/30/2024 | $ -41.46M | $ -12.84 | 1 | 3.23M |
6/30/2024 | $ -50.36M | $ -15.93 | 1 | 3.16M |
3/31/2024 | $ -34.42M | $ -16.53 | 1 | 2.08M |
12/31/2023 | $ -39.86M | $ -19.75 | 1 | 2.02M |
9/30/2023 | $ -31.74M | $ -15.61 | 1 | 2.03M |
6/30/2023 | $ -34.71M | $ -17.31 | 1 | 2M |
3/31/2023 | $ -39.2M | $ -19.62 | 1 | 2M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for SURROZEN INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 133.33K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -11.29 |
max | $ 14.03 |
average | $ 2.03 |
median | $ 1 |
std | $ 4.28 |